Suppression of MHC class I gene expression by N-myc through enhancer inactivation
- PMID: 2583102
- PMCID: PMC401475
- DOI: 10.1002/j.1460-2075.1989.tb08497.x
Suppression of MHC class I gene expression by N-myc through enhancer inactivation
Abstract
Amplification of the N-myc oncogene in human neuroblastoma is associated with increased metastatic ability. We previously found that over-expression of N-myc in rat neuroblastoma tumor cells causes a dramatic reduction in the expression of MHC class I mRNA. We show here that two distinct elements in the promoter render the MHC class I genes susceptible to N-myc-mediated suppression, one of which was identified as the MHC class I gene enhancer. Our data indicate that elevated N-myc expression is associated with reduced binding of a transcription factor that activates this enhancer. As a result, the activity of the MHC class I gene enhancer is greatly diminished. Elevated expression of the N-myc oncogene in human neuroblastomas and murine pre-B lymphoid lines also correlated with reduced factor binding to the MHC class I gene enhancer. Thus, an important effect of N-myc may be to impair the function of certain cellular enhancers by altering the levels of their cognate binding proteins.
Similar articles
-
N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.EMBO J. 1993 Jan;12(1):195-200. doi: 10.1002/j.1460-2075.1993.tb05645.x. EMBO J. 1993. PMID: 8428579 Free PMC article.
-
Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes.J Immunol. 1993 Apr 15;150(8 Pt 1):3300-10. J Immunol. 1993. PMID: 8468472
-
Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.Nucleic Acids Res. 1993 Mar 11;21(5):1179-85. doi: 10.1093/nar/21.5.1179. Nucleic Acids Res. 1993. PMID: 8464702 Free PMC article.
-
MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification.Cancer Discov. 2018 Mar;8(3):320-335. doi: 10.1158/2159-8290.CD-17-0993. Epub 2017 Dec 28. Cancer Discov. 2018. PMID: 29284669 Free PMC article.
-
Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.Verh Dtsch Ges Pathol. 1994;78:26-33. Verh Dtsch Ges Pathol. 1994. PMID: 7533996 Review.
Cited by
-
Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.Proc Natl Acad Sci U S A. 1990 Nov;87(22):8707-10. doi: 10.1073/pnas.87.22.8707. Proc Natl Acad Sci U S A. 1990. PMID: 2247438 Free PMC article.
-
N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma.EMBO J. 1991 May;10(5):1119-25. doi: 10.1002/j.1460-2075.1991.tb08052.x. EMBO J. 1991. PMID: 1902412 Free PMC article.
-
Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding.J Virol. 1992 Dec;66(12):6969-78. doi: 10.1128/JVI.66.12.6969-6978.1992. J Virol. 1992. PMID: 1433502 Free PMC article.
-
Mutations and regulatory anomalies effecting tumor cell immune functions.Cancer Immunol Immunother. 2004 Jan;53(1):1-16. doi: 10.1007/s00262-003-0418-3. Epub 2003 Sep 12. Cancer Immunol Immunother. 2004. PMID: 13680191 Free PMC article. Review.
-
N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.EMBO J. 1993 Jan;12(1):195-200. doi: 10.1002/j.1460-2075.1993.tb05645.x. EMBO J. 1993. PMID: 8428579 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials